SCHEMBL5525013

SCHEMBL5525013

CC(C)=CCN.[CaH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77915 0.96
Hydrochloric Acid SCHEMBL709143 0.93
Bromide SCHEMBL27539014 0.93
Water SCHEMBL4860496 0.93
Methyl Alcohol SCHEMBL28296236 0.93
Allylamine SCHEMBL2254965 0.84 ALDH1A1 (0.53)
Acetic Acid SCHEMBL8521540 0.84 GABRR1 (0.46)
Allylamine SCHEMBL25275445 0.82 ALDH1A1 (0.50)
Sulfur Dioxide SCHEMBL6013504 0.82 NOS1 (0.36)
SCHEMBL30461142 0.82 NOS1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed
US-7087765-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2006-08-08 US disclosed